Abstract
Randomized clinical trials have shown important clinical benefits from cardiac resynchronization therapy, in addition to those obtained with optimal medical treatment, in the advanced heart failure population. However, the criteria for inclusion in these trials are restrictive and only a small proportion of heart failure patients are candidates. The logical next step is to expand this therapy and its possible benefits to heart failure patients in less advanced stages of the disease, with narrow QRS and in atrial fibrillation. In this chapter we review the available findings on the use of this therapy in these subsets of patients.
Keywords: Heart failure, Cardiac Resynchronization Therapy, Atrial Fibrillation, Narrow QRS Complex
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Current Drug Targets - Cardiovascular & Hematological Disorders
Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Current Cardiology Reviews
Current Hypertension Reviews
Cardiovascular & Hematological Agents in Medicinal Chemistry
Cardiovascular & Hematological Disorders-Drug Targets
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents